Wan Harun Himratul-Aznita

Prof. Dr. Wan Harun Himratul-Aznita


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2015 in Frontiers in Life Science
Verified
Journal Article
Closed access
Latifah Munirah BakarLatifah Munirah Bakar
Latifah Munirah Bakar
WHWan Harun Himratul-Aznita
Wan Harun Himratul-Aznita
NZN. Mohd Zain
N. Mohd Zain
The aim of this study was to determine the effect of eugenol on the integrity of the cell wall of Candida albicans. Minimum inhibitory concentration (MIC), minimum fungicidal concentration (MFC) and percentage inhibition of diameter growth (PIDG) of eugenol on C. albicans (ATCC 14053) were determined. The effect of eugenol on the growth profile was also evaluated. The release of cellular material and changes in cell permeability, including ultrastructural alterations to the morphology, were assessed using scanning electron microscopy, and surface disruption to the cell wall structure of C. albicans by atomic force microscopy. The MIC and MFC values of eugenol were found to be 1.0% v/v, while the PIDG was dose dependent. Eugenol influenced cell growth and was fungicidal towards C. albicans. Eugenol was also found to encourage cell leakage, causing the release of cellular material, and to increase cell permeability. The ultrastructure and cell surface morphology were also altered by the presence of eugenol. Thus, eugenol was found to disrupt the cell wall of C. albicans.

1 December 2016 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
HAHayder Raad Abdulbaqi
Hayder Raad Abdulbaqi
WHWan Harun Himratul-Aznita
Wan Harun Himratul-Aznita
NBNor Baharuddin
Nor Baharuddin
In the author’s earlier in vitro investigation, a combination of 0.25 mg/ml green tea and 7.82 mg/ml Salvadora persica L. aqueous extracts was found to exhibit significant synergistic anti-bacterial and anti-adherence effects against primary plaque colonizers biofilm. A clinical trial was needed to support these preliminary in vitro results and to investigate its efficacy as a mouthwash in the control of dental plaque. A 24 h plaque re-growth, double-blinded, randomized crossover trial was carried out. Participants (n = 14) randomly rinsed with test formulation, 0.12% chlorhexidine (control) and placebo mouthwashes for 24 h. A week before the trial, all participants received scaling, polishing and oral hygiene education. On the trial day, the participants received polishing at baseline and rinsed with 15 ml of randomly allocated mouthwash twice daily without oral hygiene measures. After 24 h, plaque index was scored and then the participants entered a 6-days washout period with regular oral hygiene measures. The same protocol was repeated for the next 2 mouthwashes. The results were expressed as mean (±SD) plaque index. The test mouthwash (0.931 ± 0.372) significantly reduced plaque accumulation when compared with placebo (1.440 ± 0.498, p < 0.0167) and chlorhexidine (1.317 ± 0.344, p < 0.0167) mouthwashes. No significant difference was found between chlorhexidine and placebo (p > 0.0167). The test mouthwash has an anti-plaque effect for a 24 h period. Longer-term clinical studies are highly encouraged to investigate its anti-plaque effect for longer periods. This study was registered in ClinicalTrials.gov as NCT02624336 in December 3, 2015.

1 July 2012 in Journal of Dentistry
Verified
Journal Article
Closed access
FRFathilah Abdul Razak
Fathilah Abdul Razak
WHWan Harun Himratul-Aznita
Wan Harun Himratul-Aznita
AFA.R.N. Fatheen
A.R.N. Fatheen
KSK.R. Suriani
K.R. Suriani

30 December 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SASheela B. Abraham
Sheela B. Abraham
NANizam Abdulla
Nizam Abdulla
WHWan Harun Himratul-Aznita
Wan Harun Himratul-Aznita
MAManal Awad
Manal Awad
LSLakshman SAMARANAYAKE
Lakshman SAMARANAYAKE
HAHany Mohamed Aly Ahmed
Hany Mohamed Aly Ahmed
Objective: The indiscriminate prescription of antibiotics has led to the emergence of resistance microbes worldwide. This study aimed to investigate the antibiotic prescribing practices amongst general dental practitioners and specialists in managing endodontic infections in the United Arab Emirates (UAE). Design: General dental practitioners and specialists in the UAE were invited to participate in an online questionnaire survey which included questions on socio-demographics, practitioner’s antibiotic prescribing preferences for various pulpal and periapical diseases, and their choice, in terms of the type, dose and duration of the antibiotic. The link to the survey questionnaire was sent to 250 invited dentists. Data were analyzed by descriptive statistics and chi-square tests for independence and level of significance was set at 0.05. Results: A total of 174 respondents participated in the survey (response rate = 70%). The respondents who prescribed antibiotics at least once a month were 38.5% while 17.2% did so, more than three times a week; amoxicillin 500 mg was the antibiotic of choice for patients not allergic to penicillin (43.7%), and in cases of penicillin allergies, erythromycin 500 mg (21.3%). There was a significant difference in the antibiotic prescribing practices of GDPs compared to endodontists and other specialties especially in clinical cases such as acute apical abscesses with swelling and moderate to severe pre-operative symptoms and retreatment of endodontic cases (p<0.05). Approximately, three quarters of the respondents (78.7%) did not prescribe a loading dose when prescribing antibiotics. About 15% respondents prescribed antibiotics to their patients if they were not accessible to patients due to a holiday/weekend. Conclusions: In general, the antibiotic prescribing practices of UAE dentists are congruent with the international norms. However, there were occasions of inappropriate prescriptions such as in patients with irreversible pulpitis, necrotic pulps with no systemic involvement and/or with sinus tracts.

4 December 2013 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
MNMohd-Al-Faisal Nordin
Mohd-Al-Faisal Nordin
WHWan Harun Himratul-Aznita
Wan Harun Himratul-Aznita
FRFathilah Abdul Razak
Fathilah Abdul Razak
Candida species have been associated with the emergence of resistant strains towards selected antifungal agents. Plant products have been used traditionally as alternative medicine to ease candidal infections. The present study was undertaken to investigate the antifungal susceptibility patterns and growth inhibiting effect of Brucea javanica seeds extract against Candida species.

1 October 2016 in Archives of Oral Biology
Verified
Journal Article
Closed access
HAHayder Raad Abdulbaqi
Hayder Raad Abdulbaqi
WHWan Harun Himratul-Aznita
Wan Harun Himratul-Aznita
NBNor Adinar Baharuddin
Nor Adinar Baharuddin